Meningococcal Vaccine Market Is Set To Grow From USD 3,950.2 Million In 2024 To USD 9,014 Million By 2034, Registering A ...
"The Meningococcal Vaccine Market is on a robust growth trajectory due to the confluence of strong government mandates, rising public health awareness, and ongoing R&D efforts. The market's growth is further supported by international …